TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Laboratory Managed Serivce

Biomedical equipment
Installation services of laboratory equipment
West Midlands (UKG)
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: University Hospitals Birmingham NHS Foundation Trust: "Laboratory Managed Serivce". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityUniversity Hospitals Birmingham NHS Foundation TrustScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: University Hospitals Birmingham NHS Foundation Trust
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for University Hospitals Birmingham NHS Foundation Trust. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
8.6Bids / Report
40% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 16 active published awards; 15 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityUniversity Hospitals Birmingham NHS Foundation Trust
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published9 Dec 2022, 16:36 GMT
Last source update9 Dec 2022, 16:36 GMT
Recurring procurementNot published
ClassificationBiomedical equipment, Installation services of laboratory equipment
Delivery area
West Midlands (UKG)
OCIDocds-h6vhtk-038c67
What is being bought
Laboratory Managed Service
What changed
From the official release history
  1. Status changed to complete
    9 Dec 2022, 16:36 GMT
  2. Official notice release published
    9 Dec 2022, 16:36 GMT
  3. Buyer information updated
    9 Dec 2022, 16:36 GMT
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    Status not published
    Published valueNot published
    A Laboratory Managed Service Contract which will include equipment installation and commissioning and the supply of training, maintenance, consumables and service availability; along with the management of any third party involvement. The Supplier will provide a comprehensive managed service that will act as an enabler for the delivery of clinical services, improve outcomes and support the streamlining of clinical pathways.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    9 Dec 2022, 16:36 GMT
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 8 Dec 2022, 00:00 GMT · £41,000,000
Commercial outcome and competition
Awards
Abbott Laboratories Limited
Not published · Not published · active
Contracts
Laboratory Managed Service
£41,000,000 · signed 8 Dec 2022, 00:00 GMT · active
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

University Hospitals Birmingham NHS Foundation Trust

Contracting authority GB-FTS-154
View buyer profile

  • University Hospitals Birmingham NHS Foundation Trust
    buyer

    Mindelsohn Way, Birmingham, UKG3, B15 2WB
    daniel.o'sullivan@uhb.nhs.uk
    +44 1213712000

  • Abbott Laboratories Limited
    supplier

    00329102
    Abbott House Vanwall Business Park, Vanwall Road,, Maidenhead, UKJ, SL6 4XE

  • Royal Courts of Justice
    reviewBody

    Strand, London, WC2A
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleUniversity Hospitals Birmingham NHS Trust (UHB) intends to enter into a new contract with Abbott Laboratories Limited. The main benefit of entering into this contract revolves around the stability of application platforms while service consolidation takes place over the networks. As stated in the NHSE state of the nation document; “Consolidating pathology services allows for most consistent, clinically appropriate turnaround times ensuring the right test is available at the right time… consolidation can ensure an appropriate critical mass to support specialist diagnostics, so that patients have equal access to key tests and services are sustainable” As the capacity for change in the system is currently limited by post-Covid recovery plans, increased Emergency Department activity and other important projects for future productivity and performance (i.e. the current implantation of a new LIMS) a change of supplier will endanger the successful delivery of all of these important projects. Aligned to this a change of major analytical platform – however well planned – will always likely result is a reduction in productivity and consequently the restoration and recovery plan will be severely affected as will current ED turnaround times. It is assessed that the patients of Birmingham and Solihull will be put at a significant disadvantage if a fundamental piece of the diagnostic process undergoes change at this moment in time. Future projects will be enabled and better served by not embarking on a period of change, particularly with reference to a wider BSOL ICS consolidation – including Birmingham Women’s and Children’s Hospital. In addition, with the implementation of the LIMS across BSOL, in future we will have a digital environment which is standardised and working in all providers of laboratory services in Birmingham and Solihull, reducing the risks of making an analytical transition for the trusts and the suppliers.